IART
What one share of Integra Lifesciences Holdings holds
Surgical and Medical Instruments and Apparatus
Integra LifeSciences Holdings Corporation is a global medical technology company dedicated to restoring lives. We are advancing transformational care through impactful innovation and our portfolio of highly differentiated technologies is trusted by healthcare professionals to deliver transformative care.
Integra Lifesciences Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-09-30; the balance sheet is as of 2026-09-30.
| Sales | $21.34 |
|---|---|
| Profit | $0.17 |
| Capex (buildings and equipment) | $0.70 |
| Free cash flow | $1.10 |
| Cash and investments | $3.24 |
| Debt | $8.97 |
| Book value | $13.71 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $12.53 | $0.94 | $0.60 | $0.87 | — | $11.22 |
| 2017 | $15.02 | $0.82 | $0.55 | $0.90 | — | $12.26 |
| 2018 | $17.53 | $0.72 | $0.93 | $1.45 | — | $16.14 |
| 2019 | $17.55 | $0.58 | $0.80 | $1.87 | — | $16.78 |
| 2020 | $16.10 | $1.57 | $0.46 | $1.94 | — | $17.96 |
| 2021 | $18.04 | $1.98 | $0.56 | $3.09 | — | $20.24 |
| 2022 | $18.65 | $2.16 | $0.51 | $2.66 | — | $22.10 |
| 2023 | $19.19 | $0.84 | $0.83 | $0.91 | — | $20.30 |
| 2024 | $20.91 | −$0.09 | $1.36 | $0.32 | — | $20.01 |
| 2025 | $21.33 | −$6.74 | $1.06 | −$0.41 | — | $13.39 |